
Polyethylenimine based magnetic nanoparticles mediated non …
2020年3月12日 · We demonstrated that PEI-MNPs is a promising delivery system for plasmids encoding CRISPR/Cas9 and template DNA and thus can improve safety and utility of gene editing.
A CRISPR-Cas9 system protecting E. coli against acquisition of ...
2025年1月9日 · Therefore, we developed an engineered CRISPR-Cas9 system that protects bacteria from horizontal gene transfer. We synthesized a CRISPR locus targeting eight AMR genes and cloned this with the...
Exploring the Potential of CRISPR-Cas9 Under Challenging …
Upon CRISPR-Cas9 insertion into a model strain of E. coli harboring blaTEM–1 on the plasmid pSB1A2, the plasmid number and, accordingly, the blaTEM–1 gene expression decreased but did not become extinct in a subpopulation of CRISPR-Cas9 treated bacteria.
Near-infrared upconversion–activated CRISPR-Cas9 system: A
2019年4月3日 · As an RNA-guided nuclease, CRISPR-Cas9 offers facile and promising solutions to mediate genome modification with respect to versatility and high precision. However, spatiotemporal manipulation of CRISPR-Cas9 delivery remains a daunting challenge for robust effectuation of gene editing both in vitro and in vivo.
Dual pH-responsive CRISPR/Cas9 ribonucleoprotein
2025年2月1日 · Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR associated (Cas) protein has been proved as a powerful tool for the treatment of genetic diseases. The Cas9 protein, when combined with single-guide RNA (sgRNA), forms a Cas9/sgRNA ribonucleoprotein (RNP) capable of targeting and editing the genome.
CRISPR/Cas9-Mediated SHP-1-Knockout T cells Combined
4 天之前 · SHP-1 ablation enhances TEM cytotoxicity via IFN-γ/Granzyme B in vitro and PDX. ... RNA 36 was used to delete SHP-1 by targeting exon 3 (Figure 1A). Cas9: sgRNA ribonucleoproteins 37 were co-transfected into activated T cells using Nucleofector 4D (Lonza, Germany) and the P3 38 Primary Cell Solution Box Kit (PBP3)-02250 (Lonza, Germany). ...
Nano-Polymers as Cas9 Inhibitors - MDPI
2025年2月5日 · In an attempt to develop a nanoscale CRSIPR/Cas9 delivery platform, we discovered that several biocompatible polymers, including polymalic acid (PMLA), polyglutamic acid (PGA), and polyaspartic acid (PLD), when conjugated with a trileucine (LLL) moiety, can effectively inhibit Cas9 nuclease function.
Exploring the Potential of CRISPR-Cas9 Under Challenging Conditions ...
2020年4月30日 · One innovative approach is the CRISPR-Cas9 system which has recently been used for plasmid curing in defined strains of Escherichia coli. Here we exploited this system further under challenging conditions: by targeting the bla TEM- 1 AMR gene located on a high-copy plasmid (i.e., 100-300 copies/cell) and by directly tackling bla TEM- 1 ...
Exosome-mediated delivery of Cas9 ribonucleoprotein complexes …
2022年9月16日 · Here, we report a previously unidentified genome editing delivery system, named exosome RNP, in which Cas9 RNPs were loaded into purified exosomes isolated from hepatic stellate cells through electroporation. Exosome RNP facilitated effective cytosolic delivery of RNP in vitro while specifically accumulated in the liver tissue in vivo.
CRISPR-Cas9 library screening combined with an exosome
2024年4月29日 · Transmission electron microscopy (TEM) was used to characterize the exosomes (Exos) secreted by GBM cells after TMZ treatment. Blood-derived Exos-based targeted delivery of siRNA, TMZ, and EPIC-0412 was optimized to tailor personalized therapy in vivo.
- 某些结果已被删除